Post-translational protein modification by O-linked N-acetyl-glucosamine: Its role in mediating the adverse effects of diabetes on the heart

Life Sciences

Volumn 92, Issue 11, 2013, Pages 621-627

  McLarty, Jennifer L ^a   Marsh, Susan A ^b   Chatham, John C ^a  

^a University of Alabama at Birmingham   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Cardiomyocytes; Diabetes; O GlcNAc; O GlcNAcylation

Indexed keywords

CALCIUM; GLUCOSE; HEXOSAMINE; INSULIN; N ACETYLGLUCOSAMINE; PROTEIN;

CARBOHYDRATE SYNTHESIS; CELL STRESS; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CHROMATIN STRUCTURE; DIASTOLIC DYSFUNCTION; EPIGENETICS; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HUMAN; INSULIN RESISTANCE; LIPOTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; REVIEW;

ACETYLGLUCOSAMINE; DIABETIC CARDIOMYOPATHIES; HUMANS; INSULIN RESISTANCE; MODELS, BIOLOGICAL; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84875221904     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.08.006     Document Type: Review

References (86)

1. 2 +ATPase forms a functional interaction site with phospholamban J Biol Chem 274 1999 32855 32862
2. A.J. Bingham, L. Ooi, L. Kozera, E. White, and I.C. Wood The repressor element 1-silencing transcription factor regulates heart-specific gene expression using multiple chromatin-modifying complexes Mol Cell Biol 27 2007 4082 4092
3. D.B. Bowe, A. Sadlonova, C.A. Toleman, Z. Novak, Y. Hu, and P. Huang O-GlcNAc integrates the proteasome and transcriptome to regulate nuclear hormone receptors Mol Cell Biol 26 2006 8539 8550
4. M. Brady, M.U. Koban, K.A. Dellow, M. Yacoub, K.R. Boheler, and S.J. Fuller Sp1 and Sp3 transcription factors are required for trans-activation of the human SERCA2 promoter in cardiomyocytes Cardiovasc Res 60 2003 347 354
5. J. Brinkmann, N. Abumrad, A. Ibrahimi, G. van der Vusse, and J. Glatz New insights into long-chain fatty acid uptake by heart muscle: a crucial role for fatty acid translocase/CD36 Biochem J 367 2002 9
6. J. Buchanan, P.K. Mazumder, P. Hu, G. Chakrabarti, M.W. Roberts, and U.J. Yun Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity Endocrinology 146 2005 5341 5349
7. M.G. Buse, K.A. Robinson, B.A. Marshall, R.C. Hresko, and M.M. Mueckler Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles Am J Physiol Endocrinol Metab 283 2002 E241 E250
8. C. Chatham, and R.B. Marchase Protein O-GlcNAcylation: A critical regulator of the cellular response to stress Curr Signal Transduc Ther 5 2010 10
9. R.J. Clark, P.M. McDonough, E. Swanson, S.U. Trost, M. Suzuki, and M. Fukuda Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation J Biol Chem 278 2003 44230 44237
10. F.I. Comer, and G.W. Hart Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II Biochemistry 40 2001 7845 7852
11. S. Coort, A. Bonen, G. van der Vusse, J. Glatz, and J. Luiken Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: role of sarcolemmal substrate transporters Mol Cell Biochem 299 2007 5 18
12. R.J. Copeland, J.W. Bullen, and G.W. Hart Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity Am J Physiol Endocrinol Metab 295 2008 E17 E28
13. C.E. Crosson, S.K. Mani, S. Husain, O. Alsarraf, and D.R. Menick Inhibition of histone deacetylase protects the retina from ischemic injury Invest Ophthalmol Vis Sci 51 2010 3639 3645
14. V.M. Darley-Usmar, L.E. Ball, and J.C. Chatham Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function J Mol Cell Cardiol 52 2012 538 549
15. S. Doll, F. Paccaud, P. Bovet, M. Burnier, and V. Wietlisbach Body mass index, abdominal adiposity and blood pressure: consistency of their association across developing and developed countries Int J Obes Relat Metab Disord 26 2002 48 57
16. K. Dutta, M.W. Carmody, S.E. Cala, and A.J. Davidoff Depressed PKA activity contributes to impaired SERCA function and is linked to the pathogenesis of glucose-induced cardiomyopathy J Mol Cell Cardiol 34 2002 985 996
17. H.T. Facundo, R.E. Brainard, L.J. Watson, G.A. Ngoh, T. Hamid, and S.D. Prabhu O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy Am J Physiol Heart Circ Physiol 2012
18. Z.Y. Fang, J.B. Prins, and T.H. Marwick Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications Endocr Rev 25 2004 543 567
19. F. Fiordaliso, A. Leri, D. Cesselli, F. Limana, B. Safai, and B. Nadal-Ginard Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death Diabetes 50 2001 2363 2375
20. A. Frustaci, J. Kajstura, C. Chimenti, I. Jakoniuk, A. Leri, and A. Maseri Myocardial cell death in human diabetes Circ Res 87 2000 1123 1132
21. R. Fujiki, W. Hashiba, H. Sekine, A. Yokoyama, T. Chikanishi, and S. Ito GlcNAcylation of histone H2B facilitates its monoubiquitination Nature 480 2011 557 560
22. Gawlowski T, Suarez J, Scott B, Torres-Gonzalez M, Wang H, Schwappacher R, et al. Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-β-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes. J Biol Chem in press. http://dx.doi.org/10.1074/jbc.M112.390682
23. G.W. Hart, C. Slawson, G. Ramirez-Correa, and O. Lagerlof Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease Annu Rev Biochem 80 2011 825 858
24. M. Hawkins, N. Barzilai, R. Liu, M. Hu, W. Chen, and L. Rossetti Role of the glucosamine pathway in fat-induced insulin resistance J Clin Invest 99 1997 2173 2182
25. Y. Hu, D. Belke, J. Suarez, E. Swanson, R. Clark, and M. Hoshijima Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart Circ Res 96 2005 1006 1013
26. Y. Hu, J. Suarez, E. Fricovsky, H. Wang, B.T. Scott, and S.A. Trauger Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose J Biol Chem 284 2009 547 555
27. P. Hu, S. Shimoji, and G.W. Hart Site-specific interplay between O-GlcNAcylation and phosphorylation in cellular regulation FEBS Lett 584 2010 2526 2538
28. D.L. Hunton, P.A. Lucchesi, Y. Pang, X. Cheng, L.J. Dell'Italia, and R.B. Marchase Capacitative calcium entry contributes to nuclear factor of activated T-cells nuclear translocation and hypertrophy in cardiomyocytes J Biol Chem 277 2002 14266 14273
29. A. Jaffe, J. Spadaro, K. Schechtman, R. Roberts, E. Geitman, and B. Sobel Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus Am Heart J 108 1984 6
30. T. Jenuwein, and C.D. Allis Translating the histone code Science 293 2001 1074 1080
31. W.B. Kannel, and D.L. McGee Diabetes and cardiovascular disease: the Framingham study JAMA 241 1979 2035 2038
32. Y. Kimura, K. Kurzydlowski, M. Tada, and D.H. MacLennan Phospholamban inhibitory function is activated by depolymerization J Biol Chem 272 1997 15061 15064
33. L.K. Kreppel, M.A. Blomberg, and G.W. Hart Dynamic glycosylation of nuclear and cytosolic proteins J Biol Chem 272 1997 9308 9315
34. M. Kuang, M. Febbraio, C. Wagg, G.D. Lopaschuk, and J.R.B. Dyck Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia Circulation 109 2004 1550 1557
35. K. Kuwahara, Y. Saito, E. Ogawa, N. Takahashi, Y. Nakagawa, and Y. Naruse The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes Mol Cell Biol 21 2001 2085 2097
36. B. Laczy, N. Fulop, A. Onay-Besikci, C. Des Rosiers, and J.C. Chatham Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation PLoS One 6 2011 e18417
37. B. Laczy, N. Fülöp, A. Onay-Besikci, C. Des Rosiers, and J.C. Chatham Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation PLoS One 6 2011 e18417
38. H.B. Lee, H. Noh, J.Y. Seo, M.R. Yu, and H. Ha Histone deacetylase inhibitors: a novel class of therapeutic agents in diabetic nephropathy Kidney Int Suppl 2007 S61 S66
39. B. Levine, S.C. Sinha, and G. Kroemer Bcl-2 family members: dual regulators of apoptosis and autophagy Autophagy 4 2008 600 606
40. 2 + influx Curr Biol 15 2005 1235 1241
41. J.J.F.P. Luiken, S.L.M. Coort, J. Willems, W.A. Coumans, A. Bonen, and G.J. van der Vusse Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling Diabetes 52 2003 1627 1634
42. I.G. Lunde, J.M. Aronsen, H. Kvaløy, E. Qvigstad, I. Sjaastad, and T. Tønnessen Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure Physiol Genomics 44 2012 162 172
43. A. Makino, J. Suarez, T. Gawlowski, W. Han, H. Wang, and B.T. Scott Regulation of mitochondrial morphology and function by O-GlcNAcylation in neonatal cardiac myocytes Am J Physiol Regul Integr Comp Physiol 300 2011 R1296 R1302
44. S.A. Marsh, L.J. Dell'italia, and J.C. Chatham Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice Amino Acids 40 2011 819 828
45. S.A. Marsh, P.C. Powell, L.J. Dell'Italia, and J.C. Chatham Cardiac O-GlcNAcylation blunts autophagic signaling in the diabetic heart Life Sci 92 2013 648 656
46. J.C. Mercer, W.I. DeHaven, J.T. Smyth, B. Wedel, R.R. Boyles, and G.S. Bird Large store-operated calcium selective currents due to co-expression of Orai1 or Orai2 with the intracellular calcium sensor, Stim1 J Biol Chem 281 2006 24979 24990
47. Z. Migicovsky, and I. Kovalchuk Epigenetic memory in mammals Front Genet 2 2011 28
48. J.D. Molkentin Calcineurin and beyond: cardiac hypertrophic signaling Circ Res 87 2000 731 738
49. G.L. Morris, H.C. Cheng, J. Colyer, and J.H. Wang Phospholamban regulation of cardiac sarcoplasmic reticulum (Ca(2 +)-Mg2 +)-ATPase. Mechanism of regulation and site of monoclonal antibody interaction J Biol Chem 266 1991 11270 11275
50. T. Nagy, V. Champattanachai, R.B. Marchase, and J.C. Chatham Glucosamine inhibits angiotensin II-induced cytoplasmic Ca2 + elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine Am J Physiol Cell Physiol 290 2006 C57 C65
51. G.A. Ngoh, H.T. Facundo, A. Zafir, and S.P. Jones O-GlcNAc signaling in the cardiovascular system Circ Res 107 2010 171 185
52. Y. Nishio, C.E. Warren, J.A. Buczek-Thomas, J. Rulfs, D. Koya, and L.P. Aiello Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue J Clin Investig 96 1995 1759 1767
53. Y. Pang, D.L. Hunton, P. Bounelis, and R.B. Marchase Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes Diabetes 51 2002 3461 3467
54. Y. Pang, P. Bounelis, J.C. Chatham, and R.B. Marchase Hexosamine pathway is responsible for inhibition by diabetes of phenylephrine-induced inotropy Diabetes 53 2004 1074 1081
55. C. Peinelt, M. Vig, D.L. Koomoa, A. Beck, M.J.S. Nadler, and M. Koblan-Huberson Amplification of CRAC current by STIM1 and CRACM1 (Orai1) Nat Cell Biol 8 2006 771 773
56. S.E. Pinney, and R.A. Simmons Epigenetic mechanisms in the development of type 2 diabetes Trends Endocrinol Metab 21 2010 223 229
57. J. Ren, and A.J. Davidoff Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes Am J Physiol Heart Circ Physiol 272 1997 H148 H158
58. J. Ren, G.A. Gintant, R.E. Miller, and A.J. Davidoff High extracellular glucose impairs cardiac E-C coupling in a glycosylation-dependent manner Am J Physiol Heart Circ Physiol 273 1997 H2876 H2883
59. 2 + channel function J Cell Biol 169 2005 435 445
60. K. Sakabe, Z. Wang, and G.W. Hart {beta}-N-acetylglucosamine (O-GlcNAc) is part of the histone code Proc Natl Acad Sci U S A 107 2010 19915 19920
61. H. Takigawa-Imamura, T. Sekine, M. Murata, K. Takayama, K. Nakazawa, and J. Nakagawa Stimulation of glucose uptake in muscle cells by prolonged treatment with scriptide, a histone deacetylase inhibitor Biosci Biotechnol Biochem 67 2003 1499 1506
62. R.P. Taylor, G.J. Parker, M.W. Hazel, Y. Soesanto, W. Fuller, and M.J. Yazzie Glucose deprivation stimulates O-GlcNAc modification of proteins through upregulation of O-linked N-acetylglucosaminyltransferase J Biol Chem 283 2008 6050 6057
63. C. Toleman, A.J. Paterson, T.R. Whisenhunt, and J.E. Kudlow Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activatable O-GlcNAcase and HAT activities J Biol Chem 279 2004 53665 53673
64. C. Torres, and G. Hart Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc J Biol Chem 259 1984 3308 3317
65. T. Toyofuku, K. Kurzydlowski, M. Tada, and D.H. MacLennan Amino acids Lys-Asp-Asp-Lys-Pro-Val402 in the Ca(2 +)-ATPase of cardiac sarcoplasmic reticulum are critical for functional association with phospholamban J Biol Chem 269 1994 22929 22932
66. K. Vosseller, L. Wells, M.D. Lane, and G.W. Hart Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes Proc Natl Acad Sci 99 2002 5313 5318
67. J.L.E. Walgren, T.S. Vincent, K.L. Schey, and M.G. Buse High glucose and insulin promote O-GlcNAc modification of proteins, including α-tubulin Am J Physiol Endocrinol Metab 284 2003 E424 E434
68. P. Wang, S.G. Lloyd, H. Zeng, A. Bonen, and J.C. Chatham Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats Am J Physiol Heart Circ Physiol 288 2005 H2102 H2110
69. Z. Wang, M. Gucek, and G.W. Hart Cross-talk between GlcNAcylation and phosphorylation: site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc Proc Natl Acad Sci 105 2008 13793 13798
70. L.J. Watson, H.T. Facundo, G.A. Ngoh, M. Ameen, R.E. Brainard, and K.M. Lemma O-linked β-N-acetylglucosamine transferase is indispensable in the failing heart Proc Natl Acad Sci 107 2010 17797 17802
71. C. Weigert, K. Klopfer, C. Kausch, K. Brodbeck, M. Stumvoll, and H.U. Häring Palmitate-induced activation of the hexosamine pathway in human myotubes Diabetes 52 2003 650 656
72. T.R. Whisenhunt, X. Yang, D.B. Bowe, A.J. Paterson, B.A. Van Tine, and J.E. Kudlow Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development Glycobiology 16 2006 551 563
73. P. Xu, J. Lu, Z. Li, X. Yu, L. Chen, and T. Xu Aggregation of STIM1 underneath the plasma membrane induces clustering of Orai1 Biochem Biophys Res Commun 350 2006 969 976
74. S.F. Yan, R. Ramasamy, Y. Naka, and A.M. Schmidt Glycation, Inflammation, and RAGE Circ Res 93 2003 1159 1169
75. X. Yang, K. Su, M.D. Roos, Q. Chang, A.J. Paterson, and J.E. Kudlow O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability Proc Natl Acad Sci 98 2001 6611 6616
76. X. Yang, F. Zhang, and J.E. Kudlow Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression Cell 110 2002 69 80
77. S. Yokoe, M. Asahi, T. Takeda, K. Otsu, N. Taniguchi, and E. Miyoshi Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy Glycobiology 20 2010 1217 1226
78. N.E. Zachara The roles of O-linked β-N-acetylglucosamines (O-GlcNAc) in cardiovascular physiology and disease Am J Physiol Heart Circ Physiol 302 2012 1905 1918
79. N.E. Zachara, and G.W. Hart Cell signaling, the essential role of O-GlcNAc! Biochim Biophys Acta 1761 2006 599 617
80. N.E. Zachara, N. O'Donnell, W.D. Cheung, J.J. Mercer, J.D. Marth, and G.W. Hart Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells J Biol Chem 279 2004 30133 30142
81. T. Zhang, S. Miyamoto, and J.H. Brown Cardiomyocyte calcium and calcium/calmodulin-dependent protein kinase II: friends or foes? Recent Prog Horm Res 59 2004 141 168
82. 2 + store to the plasma membrane Nature 437 2005 902 905
83. 2 + channel activity Proc Natl Acad Sci 103 2006 9357 9362
84. Z.Q. Zhao, J.S. Corvera, M.E. Halkos, F. Kerendi, N.P. Wang, and R.A. Guyton Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am J Physiol Heart Circ Physiol 285 2003 H579 H588
85. X. Zhu, L. Zou, S.A. Marsh, R.B. Marchase, and J.C. Chatham Inhibition of STIM1 oligomerization by protein O-linked N-actelylglucosamine: a novel metabolically mediated regulation of cardiomyocyte calcium overload Circulation 122 2010 A18259
86. Zou L, Zhu-Mauldin X, Marchase RB, Paterson AJ, Liu J, Yang Q, Chatham JC. Glucose deprivation induced increase in protein O-GlcNAcylation in cardiomyocytes is calcium dependent. J Biol Chem published in press. http://dx.doi.org/10.1074/jbc.M112.393207.